A phase I clinical trial of A501M (benzimate oral solution) [carbendazim] administered to patients with metastatic cancer or disseminated malignancy
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2006
At a glance
- Drugs Carbendazim (Primary)
- Indications Cancer
- Focus Adverse reactions
- 03 Aug 2006 New trial record.